{"DataElement":{"publicId":"6829500","version":"1","preferredName":"Renal Cell Carcinoma Histologic Primary Non Clear Cell Classification Type","preferredDefinition":"The type of histologic primary non clear cell classification of renal cell carcinoma.","longName":"6828143v1.0:6829464v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6828143","version":"1","preferredName":"Renal Cell Carcinoma Histologic Primary Negation Clear Cell Classification","preferredDefinition":"The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._Occurring first in time or sequence; original; of greatest rank or importance or value._An operation in which a term denies or inverts the meaning of another term or construction._A cell with empty-appearing cytoplasm when viewed with a light microscope._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2428360v1.0:6828141v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2428360","version":"1","preferredName":"Renal Cell Carcinoma","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"C9385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0826-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6828141","version":"1","preferredName":"Histologic Primary Negation Clear Cell Classification","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:Occurring first in time or sequence; original; of greatest rank or importance or value.:An operation in which a term denies or inverts the meaning of another term or construction.:A cell with empty-appearing cytoplasm when viewed with a light microscope.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"6828141v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E848A06-60A2-7CC1-E053-F662850AD6AA","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E848A06-60B3-7CC1-E053-F662850AD6AA","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6829464","version":"1","preferredName":"Renal Cell Carcinoma Histologic Primary Non Clear Cell Type","preferredDefinition":"The type of histologic primary non clear cell type in renal cell carcinoma.","longName":"6829464v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"500","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unclassified","valueDescription":"Unclassified Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118711","version":"1","preferredName":"Unclassified Renal Cell Carcinoma","longName":"5118711","preferredDefinition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified Renal Cell Carcinoma","conceptCode":"C27892","definition":"A renal cell carcinoma characterized by morphologic features that do not fit easily into one of the other well-defined categories of renal cell carcinoma. Examples of such features include mixtures of morphologic patterns, mucin production, and sarcomatoid morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-3928-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-545D-63F4-E053-F662850A2775","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-5471-63F4-E053-F662850A2775","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Chromophobe","valueDescription":"Chromophobe Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118714","version":"1","preferredName":"Chromophobe Renal Cell Carcinoma","longName":"5118714","preferredDefinition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromophobe Renal Cell Carcinoma","conceptCode":"C4146","definition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic.  It has a much better prognosis than other renal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-397C-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-5485-63F4-E053-F662850A2775","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Collecting duct carcinoma","valueDescription":"Carcinoma of the Collecting Ducts of Bellini","ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-548F-63F4-E053-F662850A2775","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Medullary carcinoma","valueDescription":"Kidney Medullary Carcinoma","ValueMeaning":{"publicId":"5210416","version":"1","preferredName":"Kidney Medullary Carcinoma","longName":"5210416","preferredDefinition":"A recently described type of renal carcinoma, affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Medullary Carcinoma","conceptCode":"C7572","definition":"A type of renal carcinoma affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-656F-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-54A3-63F4-E053-F662850A2775","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"},{"value":"Translocation","valueDescription":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","ValueMeaning":{"publicId":"5210414","version":"1","preferredName":"Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions","longName":"5210414","preferredDefinition":"A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2.  These translocations result in the creation of gene fusions involving the TFE3 gene.  Patients are usually children and young adults.  Morphologically, the malignant epithelial cells form papillary patterns.  The clinical behavior of this group of carcinomas is largely unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TFE3-Rearranged Renal Cell Carcinoma","conceptCode":"C27891","definition":"A group of renal cell carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-6549-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E84F71D-54AD-63F4-E053-F662850A2775","beginDate":"2019-03-28","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E84F71D-543D-63F4-E053-F662850A2775","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"non clear cell type","type":"Preferred Question Text","description":"non clear cell type","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E853C1A-09B8-1E20-E053-F662850A100A","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"MORENOC","dateModified":"2020-01-09","changeDescription":"1/9/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}